期刊文献+

Anti-inflammatory activity of probiotic Bifidobacterium: Enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells 被引量:38

Anti-inflammatory activity of probiotic Bifidobacterium: Enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells
下载PDF
导出
摘要 AIM: To determine the anti-inflammatory activity of probiotic Bifidobacteria in Bifidobacteria-fermented milk (BFM) which is effective against active ulcerative colitis (UC) and exacerbations of UC, and to explore the immunoregulatory mechanisms. METHODS: Peripheral blood mononuclear cells (PBMNC) from UC patients or HT-29 cells were co-cultured with heat-killed probiotic bacteria or culture supernatant of Bifidobacterium breve strain Yakult (BbrY) or Bifidobacterium bifidum strain Yakult (BbiY) to estimate the amount of IL-10 or IL-8 secreted. RESULTS: Both strains of probiotic Bifidobacteria contained in the BFM induced IL-10 production in PBMNC from UC patients, though BbrY was more effective than BbiY. Conditioned medium (CM) and DNA of both strains inhibited IL-8 secretion in HT-29 cells stimulated with TNF-α, whereas no such effect was observed with heat- killed bacteria. The inhibitory effect of CM derived from BbiY was greater than that of CM derived from BbrY. DNAs of the two strains had a comparable inhibitory activity against the secretion of IL-8. CM of BbiY induced a repression of IL-8 gene expression with a higher expression of IκB-ζ mRNA 4 h after culture of HT-29 cells compared to that in the absence of CM.CONCLUSION: Probiotic Bifidobacterium strains in BFM enhance IL-10 production in PBMNC and inhibit IL-8 secretion in intestinal epithelial cells, suggesting that BFM has anti-inflammatory effects against ulcerative colitis. AIM: To determine the anti-inflammatory activity of probiotic Bifidobacteria in Bifidobacteria-fermented milk (BFM) which is effective against active ulcerative colitis (UC) and exacerbations of UC, and to explore the immunoregulatory mechanisms. METHODS: Peripheral blood mononuclear cells (PBMNC) from UC patients or HT-29 cells were co-cultured with heat-killed probiotic bacteria or culture supernatant of Bifidobacterium breve strain Yakult (BbrY) or Bifidobacterium bifidum strain Yakult (BbiY) to estimate the amount of IL-10 or IL-8 secreted. RESULTS: Both strains of probiotic Bifidobacteria contained in the BFM induced IL-10 production in PBMNC from UC patients, though BbrY was more effective than BbiY. Conditioned medium (CM) and DNA of both strains inhibited IL-8 secretion in HT-29 cells stimulated with TNF-α, whereas no such effect was observed with heat- killed bacteria. The inhibitory effect of CM derived from BbiY was greater than that of CM derived from BbrY. DNAs of the two strains had a comparable inhibitory activity against the secretion of IL-8. CM of BbiY induced a repression of IL-8 gene expression with a higher expression of IκB-ζ mRNA 4 h after culture of HT-29 cells compared to that in the absence of CM.CONCLUSION: Probiotic Bifidobacterium strains in BFM enhance IL-10 production in PBMNC and inhibit IL-8 secretion in intestinal epithelial cells, suggesting that BFM has anti-inflammatory effects against ulcerative colitis.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第16期2511-2516,共6页 世界胃肠病学杂志(英文版)
关键词 BIFIDOBACTERIUM Ulcerative colitis ANTI-INFLAMMATORY Intedeukin-10 INTERLEUKIN-8 大肠炎 非急性疾病 白介素-8 双歧杆菌
  • 相关文献

参考文献11

  • 1Krishna P. Reddy,Jonathan E. Markowitz,Eduardo D. Ruchelli,Robert N. Baldassano,Kurt A. Brown.Lamina Propria and Circulating Interleukin-8 in Newly and Previously Diagnosed Pediatric Inflammatory Bowel Disease Patients[J].Digestive Diseases and Sciences.2007(2) 被引量:1
  • 2Sartor RB.Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics[].Gastroenterology.2004 被引量:1
  • 3Campieri M,Gionchetti P.Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?[].Gastroenterology.1999 被引量:1
  • 4Furrie E,Macfarlane S,Kennedy A,Cummings JH,Walsh SV,O‘neil DA,Macfarlane GT.Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial[].Gut.2005 被引量:1
  • 5Kato K,Mizuno S,Umesaki Y,Ishii Y,Sugitani M,Imaoka A,Otsuka M,Hasunuma O,Kurihara R,Iwasaki A,Arakawa Y.Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis[].Alimentary Pharmacology and Therapeutics.2004 被引量:1
  • 6Rennick DM,Fort MM.Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation[].American Journal of Physiology Gastrointestinal and Liver Physiology.2000 被引量:1
  • 7Asseman C,Read S,Powrie F.Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10[].J Immunol.2003 被引量:1
  • 8Takahashi I,Matsuda J,Gapin L,DeWinter H,Kai Y,Tamagawa H,Kronenberg M,Kiyono H.Colitis-related public T cells are selected in the colonic lamina propria of IL-10- deficient mice[].Clinical Immunology.2002 被引量:1
  • 9Sydora BC,Tavernini MM,Wessler A,Jewell LD,Fedorak RN.Lack of interleukin-10 leads to intestinal inflammation, independent of the time at which luminal microbial colonization occurs[].Inflammatory Bowel Diseases.2003 被引量:1
  • 10Benoit Foligne,Sophie Nutten,Corinne Grangette,Véronique Dennin,Denise Goudercourt,Sabine Poiret,Joelle Dewulf,Dominique Brassart,Annick Mercenier,Bruno Pot.Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria[J].World Journal of Gastroenterology,2007,13(2):236-243. 被引量:22

二级参考文献1

共引文献21

同被引文献294

引证文献38

二级引证文献322

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部